Figure 4

Association between the expression level of HAUS5 and clinical features in LIHC analyzed via the UALCAN database. HAUS5 differential expression in liver cancer patients according to the characteristics of age (A), sex (B), race (C), tumor grade (D), cancer stage (E) and TP53 mutation status (F). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.